KeyBanc Capital Markets将Codex DNA的目标价从8美元调整为5美元,维持增持评级
MT Newswires2022/11/09 09:43 (美东)
Codex DNA分析师评级
Benzinga Analyst Ratings2022/11/09 04:51 (美东)
KeyBanc维持增持Codex DNA,将目标价下调至5美元
Benzinga Real-time News2022/11/09 04:51 (美东)
暂无数据